Rebecca Rohlfs, Ph.D., is a Senior Scientist at Novo Nordisk since November 2020, with previous experience as a Senior Scientist at Alkermes from August 2016 to November 2020, focusing on bioanalytical development. Prior roles include a Research Associate at Cincinnati Children's Hospital Medical Center, where research involved proteomics related to cystic fibrosis, and a Senior Scientist I at Merial, a Sanofi Company, responsible for analytical method development. Education includes a Ph.D. in Bioanalytical Chemistry from the University of Cincinnati and a BS in Chemistry from Xavier University. Dissertation research concentrated on liquid chromatography and mass spectrometry analysis of post-transcriptional modifications of rRNA.
This person is not in any teams
This person is not in any offices
Novo Nordisk
343 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.